Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Inhibition of glioblastoma cell proliferation, invasion, and mechanism of action of a novel hydroxamic acid hybrid molecule.

Zhang I, Beus M, Stochaj U, Le PU, Zorc B, Rajić Z, Petrecca K, Maysinger D.

Cell Death Discov. 2018 Sep 26;4:41. doi: 10.1038/s41420-018-0103-0. eCollection 2018.

2.

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP, Aiken R, Chaudhary R, Goldlust SA, Bota DA, Duic P, Grewal J, Elinzano H, Toms SA, Lillehei KO, Mikkelsen T, Walbert T, Abram SR, Brenner AJ, Brem S, Ewend MG, Khagi S, Portnow J, Kim LJ, Loudon WG, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Lindhorst S, Lutzky J, Sloan AE, Schackert G, Krex D, Meisel HJ, Wu J, Davis RP, Duma C, Etame AB, Mathieu D, Kesari S, Piccioni D, Westphal M, Baskin DS, New PZ, Lacroix M, May SA, Pluard TJ, Tse V, Green RM, Villano JL, Pearlman M, Petrecca K, Schulder M, Taylor LP, Maida AE, Prins RM, Cloughesy TF, Mulholland P, Bosch ML.

J Transl Med. 2018 Jun 29;16(1):179. doi: 10.1186/s12967-018-1552-1.

3.

Dual MAPK Inhibition Is an Effective Therapeutic Strategy for a Subset of Class II BRAF Mutant Melanomas.

Dankner M, Lajoie M, Moldoveanu D, Nguyen TT, Savage P, Rajkumar S, Huang X, Lvova M, Protopopov A, Vuzman D, Hogg D, Park M, Guiot MC, Petrecca K, Mihalcioiu C, Watson IR, Siegel PM, Rose AAN.

Clin Cancer Res. 2018 Dec 15;24(24):6483-6494. doi: 10.1158/1078-0432.CCR-17-3384. Epub 2018 Jun 14.

PMID:
29903896
4.

DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapy.

Bernier C, Soliman A, Gravel M, Dankner M, Savage P, Petrecca K, Park M, Siegel PM, Shore GC, Roulston A.

Anticancer Drugs. 2018 Sep;29(8):774-785. doi: 10.1097/CAD.0000000000000653.

5.

Antibody-Antisense Oligonucleotide Conjugate Downregulates a Key Gene in Glioblastoma Stem Cells.

Arnold AE, Malek-Adamian E, Le PU, Meng A, Martínez-Montero S, Petrecca K, Damha MJ, Shoichet MS.

Mol Ther Nucleic Acids. 2018 Jun 1;11:518-527. doi: 10.1016/j.omtn.2018.04.004. Epub 2018 Apr 19.

6.

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP, Aiken R, Chaudhary R, Goldlust SA, Bota DA, Duic P, Grewal J, Elinzano H, Toms SA, Lillehei KO, Mikkelsen T, Walbert T, Abram SR, Brenner AJ, Brem S, Ewend MG, Khagi S, Portnow J, Kim LJ, Loudon WG, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Lindhorst S, Lutzky J, Sloan AE, Schackert G, Krex D, Meisel HJ, Wu J, Davis RP, Duma C, Etame AB, Mathieu D, Kesari S, Piccioni D, Westphal M, Baskin DS, New PZ, Lacroix M, May SA, Pluard TJ, Tse V, Green RM, Villano JL, Pearlman M, Petrecca K, Schulder M, Taylor LP, Maida AE, Prins RM, Cloughesy TF, Mulholland P, Bosch ML.

J Transl Med. 2018 May 29;16(1):142. doi: 10.1186/s12967-018-1507-6. Erratum in: J Transl Med. 2018 Jun 29;16(1):179.

7.

Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma (INTRAGO): An Open-Label, Dose-Escalation Phase I/II Trial.

Giordano FA, Brehmer S, Mürle B, Welzel G, Sperk E, Keller A, Abo-Madyan Y, Scherzinger E, Clausen S, Schneider F, Herskind C, Glas M, Seiz-Rosenhagen M, Groden C, Hänggi D, Schmiedek P, Emami B, Souhami L, Petrecca K, Wenz F.

Neurosurgery. 2019 Jan 1;84(1):41-49. doi: 10.1093/neuros/nyy018.

PMID:
29528443
8.

Combining intraoperative ultrasound brain shift correction and augmented reality visualizations: a pilot study of eight cases.

Gerard IJ, Kersten-Oertel M, Drouin S, Hall JA, Petrecca K, De Nigris D, Di Giovanni DA, Arbel T, Collins DL.

J Med Imaging (Bellingham). 2018 Apr;5(2):021210. doi: 10.1117/1.JMI.5.2.021210. Epub 2018 Jan 26.

PMID:
29392162
9.

A new method using Raman spectroscopy for in vivo targeted brain cancer tissue biopsy.

Desroches J, Jermyn M, Pinto M, Picot F, Tremblay MA, Obaid S, Marple E, Urmey K, Trudel D, Soulez G, Guiot MC, Wilson BC, Petrecca K, Leblond F.

Sci Rep. 2018 Jan 29;8(1):1792. doi: 10.1038/s41598-018-20233-3.

10.

Prognostic factors for progression in atypical meningioma.

Shakir SI, Souhami L, Petrecca K, Mansure JJ, Singh K, Panet-Raymond V, Shenouda G, Al-Odaini AA, Abdulkarim B, Guiot MC.

J Neurosurg. 2018 Jan 19:1-9. doi: 10.3171/2017.6.JNS17120. [Epub ahead of print]

PMID:
29350599
11.

Development and characterization of a handheld hyperspectral Raman imaging probe system for molecular characterization of tissue on mesoscopic scales.

St-Arnaud K, Aubertin K, Strupler M, Madore WJ, Grosset AA, Petrecca K, Trudel D, Leblond F.

Med Phys. 2018 Jan;45(1):328-339. doi: 10.1002/mp.12657. Epub 2017 Nov 27.

PMID:
29106741
12.

A Targetable EGFR-Dependent Tumor-Initiating Program in Breast Cancer.

Savage P, Blanchet-Cohen A, Revil T, Badescu D, Saleh SMI, Wang YC, Zuo D, Liu L, Bertos NR, Munoz-Ramos V, Basik M, Petrecca K, Asselah J, Meterissian S, Guiot MC, Omeroglu A, Kleinman CL, Park M, Ragoussis J.

Cell Rep. 2017 Oct 31;21(5):1140-1149. doi: 10.1016/j.celrep.2017.10.015.

13.

Highly Accurate Detection of Cancer In Situ with Intraoperative, Label-Free, Multimodal Optical Spectroscopy.

Jermyn M, Mercier J, Aubertin K, Desroches J, Urmey K, Karamchandiani J, Marple E, Guiot MC, Leblond F, Petrecca K.

Cancer Res. 2017 Jul 15;77(14):3942-3950. doi: 10.1158/0008-5472.CAN-17-0668. Epub 2017 Jun 28.

14.

Harnessing the hygroscopic and biofluorescent behaviors of genetically tractable microbial cells to design biohybrid wearables.

Wang W, Yao L, Cheng CY, Zhang T, Atsumi H, Wang L, Wang G, Anilionyte O, Steiner H, Ou J, Zhou K, Wawrousek C, Petrecca K, Belcher AM, Karnik R, Zhao X, Wang DIC, Ishii H.

Sci Adv. 2017 May 19;3(5):e1601984. doi: 10.1126/sciadv.1601984. eCollection 2017 May.

15.

Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.

Azoulay M, Santos F, Shenouda G, Petrecca K, Oweida A, Guiot MC, Owen S, Panet-Raymond V, Souhami L, Abdulkarim BS.

J Neurooncol. 2017 May;132(3):419-426. doi: 10.1007/s11060-017-2383-2. Epub 2017 Apr 3.

PMID:
28374095
16.

Raman spectroscopy detects distant invasive brain cancer cells centimeters beyond MRI capability in humans.

Jermyn M, Desroches J, Mercier J, St-Arnaud K, Guiot MC, Leblond F, Petrecca K.

Biomed Opt Express. 2016 Nov 16;7(12):5129-5137. doi: 10.1364/BOE.7.005129. eCollection 2016 Dec 1.

17.

A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With Glioblastoma.

Shenouda G, Souhami L, Petrecca K, Owen S, Panet-Raymond V, Guiot MC, Corredor AG, Abdulkarim B.

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):487-494. doi: 10.1016/j.ijrobp.2016.11.006. Epub 2016 Nov 15.

PMID:
28011051
18.

Wide-field spontaneous Raman spectroscopy imaging system for biological tissue interrogation.

St-Arnaud K, Aubertin K, Strupler M, Jermyn M, Petrecca K, Trudel D, Leblond F.

Opt Lett. 2016 Oct 15;41(20):4692-4695. doi: 10.1364/OL.41.004692.

PMID:
28005869
19.

Raman spectroscopy in microsurgery: impact of operating microscope illumination sources on data quality and tissue classification.

Desroches J, Laurence A, Jermyn M, Pinto M, Tremblay MA, Petrecca K, Leblond F.

Analyst. 2017 Apr 10;142(8):1185-1191. doi: 10.1039/c6an02061e.

PMID:
27845785
20.

A review of Raman spectroscopy advances with an emphasis on clinical translation challenges in oncology.

Jermyn M, Desroches J, Aubertin K, St-Arnaud K, Madore WJ, De Montigny E, Guiot MC, Trudel D, Wilson BC, Petrecca K, Leblond F.

Phys Med Biol. 2016 Dec 7;61(23):R370-R400. Epub 2016 Nov 2. Review.

PMID:
27804917
21.

Progression pattern and adverse events with bevacizumab in glioblastoma.

Mamo A, Baig A, Azam M, Rho YS, Sahebjam S, Muanza T, Owen S, Petrecca K, Guiot MC, Al-Shami J, Sharma R, Kavan P.

Curr Oncol. 2016 Oct;23(5):e468-e471. Epub 2016 Oct 25.

22.

Inhibition of carbonic anhydrase IX in glioblastoma multiforme.

Amiri A, Le PU, Moquin A, Machkalyan G, Petrecca K, Gillard JW, Yoganathan N, Maysinger D.

Eur J Pharm Biopharm. 2016 Dec;109:81-92. doi: 10.1016/j.ejpb.2016.09.018. Epub 2016 Oct 1.

PMID:
27702686
23.

The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway.

Carbonneau M, M Gagné L, Lalonde ME, Germain MA, Motorina A, Guiot MC, Secco B, Vincent EE, Tumber A, Hulea L, Bergeman J, Oppermann U, Jones RG, Laplante M, Topisirovic I, Petrecca K, Huot MÉ, Mallette FA.

Nat Commun. 2016 Sep 14;7:12700. doi: 10.1038/ncomms12700.

24.

Neural networks improve brain cancer detection with Raman spectroscopy in the presence of operating room light artifacts.

Jermyn M, Desroches J, Mercier J, Tremblay MA, St-Arnaud K, Guiot MC, Petrecca K, Leblond F.

J Biomed Opt. 2016 Sep 1;21(9):94002. doi: 10.1117/1.JBO.21.9.094002.

PMID:
27604560
25.

Brain shift in neuronavigation of brain tumors: A review.

Gerard IJ, Kersten-Oertel M, Petrecca K, Sirhan D, Hall JA, Collins DL.

Med Image Anal. 2017 Jan;35:403-420. doi: 10.1016/j.media.2016.08.007. Epub 2016 Aug 24. Review.

PMID:
27585837
26.

IBIS: an OR ready open-source platform for image-guided neurosurgery.

Drouin S, Kochanowska A, Kersten-Oertel M, Gerard IJ, Zelmann R, De Nigris D, Bériault S, Arbel T, Sirhan D, Sadikot AF, Hall JA, Sinclair DS, Petrecca K, DelMaestro RF, Collins DL.

Int J Comput Assist Radiol Surg. 2017 Mar;12(3):363-378. doi: 10.1007/s11548-016-1478-0. Epub 2016 Aug 31. Review.

PMID:
27581336
27.

Sensitivity to PRIMA-1MET is associated with decreased MGMT in human glioblastoma cells and glioblastoma stem cells irrespective of p53 status.

Patyka M, Sharifi Z, Petrecca K, Mansure J, Jean-Claude B, Sabri S.

Oncotarget. 2016 Sep 13;7(37):60245-60269. doi: 10.18632/oncotarget.11197.

28.

Decompressive Craniectomy for Ischemic Stroke: Effect of Hemorrhagic Transformation on Outcome.

Al-Jehani H, Petrecca K, Martel P, Sinclair D, Sirhan D.

J Stroke Cerebrovasc Dis. 2016 Sep;25(9):2177-83. doi: 10.1016/j.jstrokecerebrovasdis.2015.12.039. Epub 2016 Jul 25.

PMID:
27468660
29.

Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis.

Ramaswamy V, Hielscher T, Mack SC, Lassaletta A, Lin T, Pajtler KW, Jones DT, Luu B, Cavalli FM, Aldape K, Remke M, Mynarek M, Rutkowski S, Gururangan S, McLendon RE, Lipp ES, Dunham C, Hukin J, Eisenstat DD, Fulton D, van Landeghem FK, Santi M, van Veelen ML, Van Meir EG, Osuka S, Fan X, Muraszko KM, Tirapelli DP, Oba-Shinjo SM, Marie SK, Carlotti CG, Lee JY, Rao AA, Giannini C, Faria CC, Nunes S, Mora J, Hamilton RL, Hauser P, Jabado N, Petrecca K, Jung S, Massimi L, Zollo M, Cinalli G, Bognár L, Klekner A, Hortobágyi T, Leary S, Ermoian RP, Olson JM, Leonard JR, Gardner C, Grajkowska WA, Chambless LB, Cain J, Eberhart CG, Ahsan S, Massimino M, Giangaspero F, Buttarelli FR, Packer RJ, Emery L, Yong WH, Soto H, Liau LM, Everson R, Grossbach A, Shalaby T, Grotzer M, Karajannis MA, Zagzag D, Wheeler H, von Hoff K, Alonso MM, Tuñon T, Schüller U, Zitterbart K, Sterba J, Chan JA, Guzman M, Elbabaa SK, Colman H, Dhall G, Fisher PG, Fouladi M, Gajjar A, Goldman S, Hwang E, Kool M, Ladha H, Vera-Bolanos E, Wani K, Lieberman F, Mikkelsen T, Omuro AM, Pollack IF, Prados M, Robins HI, Soffietti R, Wu J, Metellus P, Tabori U, Bartels U, Bouffet E, Hawkins CE, Rutka JT, Dirks P, Pfister SM, Merchant TE, Gilbert MR, Armstrong TS, Korshunov A, Ellison DW, Taylor MD.

J Clin Oncol. 2016 Jul 20;34(21):2468-77. doi: 10.1200/JCO.2015.65.7825. Epub 2016 Jun 6.

30.

Rationale for intraoperative radiotherapy in glioblastoma.

Giordano FA, Wenz F, Petrecca K.

J Neurosurg Sci. 2016 Sep;60(3):350-6. Epub 2016 Jan 29. Review.

PMID:
26824195
31.

Improved sensitivity to fluorescence for cancer detection in wide-field image-guided neurosurgery.

Jermyn M, Gosselin Y, Valdes PA, Sibai M, Kolste K, Mercier J, Angulo L, Roberts DW, Paulsen KD, Petrecca K, Daigle O, Wilson BC, Leblond F.

Biomed Opt Express. 2015 Nov 30;6(12):5063-74. doi: 10.1364/BOE.6.005063. eCollection 2015 Dec 1.

32.

Characterization of a Raman spectroscopy probe system for intraoperative brain tissue classification.

Desroches J, Jermyn M, Mok K, Lemieux-Leduc C, Mercier J, St-Arnaud K, Urmey K, Guiot MC, Marple E, Petrecca K, Leblond F.

Biomed Opt Express. 2015 Jun 8;6(7):2380-97. doi: 10.1364/BOE.6.002380. eCollection 2015 Jul 1.

33.

Comparison of radiation regimens in the treatment of Glioblastoma multiforme: results from a single institution.

Azoulay M, Santos F, Souhami L, Panet-Raymond V, Petrecca K, Owen S, Guiot MC, Patyka M, Sabri S, Shenouda G, Abdulkarim B.

Radiat Oncol. 2015 Apr 26;10:106. doi: 10.1186/s13014-015-0396-6.

34.

Macroscopic-imaging technique for subsurface quantification of near-infrared markers during surgery.

Jermyn M, Kolste K, Pichette J, Sheehy G, Angulo-Rodríguez L, Paulsen KD, Roberts DW, Wilson BC, Petrecca K, Leblond F.

J Biomed Opt. 2015 Mar;20(3):036014. doi: 10.1117/1.JBO.20.3.036014.

35.

Sub-diffuse interstitial optical tomography to improve the safety of brain needle biopsies: a proof-of-concept study.

Goyette A, Pichette J, Tremblay MA, Laurence A, Jermyn M, Mok K, Paulsen KD, Roberts DW, Petrecca K, Wilson BC, Leblond F.

Opt Lett. 2015 Jan 15;40(2):170-3. doi: 10.1364/OL.40.000170.

PMID:
25679836
36.

Intraoperative brain cancer detection with Raman spectroscopy in humans.

Jermyn M, Mok K, Mercier J, Desroches J, Pichette J, Saint-Arnaud K, Bernstein L, Guiot MC, Petrecca K, Leblond F.

Sci Transl Med. 2015 Feb 11;7(274):274ra19. doi: 10.1126/scitranslmed.aaa2384.

PMID:
25673764
37.

Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma.

Di Stefano AL, Fucci A, Frattini V, Labussiere M, Mokhtari K, Zoppoli P, Marie Y, Bruno A, Boisselier B, Giry M, Savatovsky J, Touat M, Belaid H, Kamoun A, Idbaih A, Houillier C, Luo FR, Soria JC, Tabernero J, Eoli M, Paterra R, Yip S, Petrecca K, Chan JA, Finocchiaro G, Lasorella A, Sanson M, Iavarone A.

Clin Cancer Res. 2015 Jul 15;21(14):3307-17. doi: 10.1158/1078-0432.CCR-14-2199. Epub 2015 Jan 21.

38.

Arabinonucleic acids: 2'-stereoisomeric modulators of siRNA activity.

Anzahaee MY, Deleavey GF, Le PU, Fakhoury J, Petrecca K, Damha MJ.

Nucleic Acid Ther. 2014 Oct;24(5):336-43. doi: 10.1089/nat.2014.0496. Epub 2014 Aug 27.

PMID:
25162466
39.

Celastrol targets proteostasis and acts synergistically with a heat-shock protein 90 inhibitor to kill human glioblastoma cells.

Boridy S, Le PU, Petrecca K, Maysinger D.

Cell Death Dis. 2014 May 8;5:e1216. doi: 10.1038/cddis.2014.182.

40.

Patterns of care at end of life for people with primary intracranial tumors: lessons learned.

Alturki A, Gagnon B, Petrecca K, Scott SC, Nadeau L, Mayo N.

J Neurooncol. 2014 Mar;117(1):103-15. doi: 10.1007/s11060-014-1360-2. Epub 2014 Jan 28.

PMID:
24469851
41.

DRR regulates AKT activation to drive brain cancer invasion.

Dudley A, Sater M, Le PU, Trinh G, Sadr MS, Bergeron J, Deleavey GF, Bedell B, Damha MJ, Petrecca K.

Oncogene. 2014 Oct 9;33(41):4952-60. doi: 10.1038/onc.2013.436. Epub 2013 Oct 21.

PMID:
24141773
42.

Short Interval Infield Sarcoma Development following Resection of Glioblastoma and Adjuvant Radiotherapy and Temozolomide.

Alotaibi FE, Petrecca K.

Case Rep Med. 2013;2013:591272. doi: 10.1155/2013/591272. Epub 2013 Aug 29.

43.

Bevacizumab use for recurrent high-grade glioma at McGill University Hospital.

Sahebjam S, Garoufalis E, Guiot MC, Muanza T, Del Maestro R, Petrecca K, Sharma R, Kavan P.

Can J Neurol Sci. 2013 Mar;40(2):241-6.

PMID:
23419575
44.

Registering pre- and postresection 3-dimensional ultrasound for improved visualization of residual brain tumor.

Mercier L, Araujo D, Haegelen C, Del Maestro RF, Petrecca K, Collins DL.

Ultrasound Med Biol. 2013 Jan;39(1):16-29. doi: 10.1016/j.ultrasmedbio.2012.08.004.

PMID:
23200177
45.

The case for mini-craniotomy in the management of chronic subdural hematoma.

Al-Jehani H, Petrecca K.

Acta Neurochir (Wien). 2013 Jan;155(1):189-90. doi: 10.1007/s00701-012-1539-2. Epub 2012 Oct 30. No abstract available.

PMID:
23108560
46.

Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma.

Petrecca K, Guiot MC, Panet-Raymond V, Souhami L.

J Neurooncol. 2013 Jan;111(1):19-23. doi: 10.1007/s11060-012-0983-4. Epub 2012 Oct 10.

PMID:
23054563
47.

Online database of clinical MR and ultrasound images of brain tumors.

Mercier L, Del Maestro RF, Petrecca K, Araujo D, Haegelen C, Collins DL.

Med Phys. 2012 Jun;39(6):3253-61. doi: 10.1118/1.4709600.

PMID:
22755708
48.

Pineal apoplexy: imaging diagnosis and follow-up of three new cases.

Asundi A, Tampieri D, Melançon D, Del Maestro R, Petrecca K, Cortes MD.

Can J Neurol Sci. 2011 Nov;38(6):931-3. No abstract available.

PMID:
22030436
49.

Rarest of the rare: Chordoid glioma infiltrating the optic chiasm.

Al Hinai QS, Petrecca K.

Surg Neurol Int. 2011;2:53. doi: 10.4103/2152-7806.80118. Epub 2011 Apr 28.

50.

Comparing two approaches to rigid registration of three-dimensional ultrasound and magnetic resonance images for neurosurgery.

Mercier L, Fonov V, Haegelen C, Del Maestro RF, Petrecca K, Collins DL.

Int J Comput Assist Radiol Surg. 2012 Jan;7(1):125-36. doi: 10.1007/s11548-011-0620-2. Epub 2011 Jun 2.

PMID:
21633799

Supplemental Content

Loading ...
Support Center